Total amount: € 0,00
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536
Online ISSN 1827-1758
Service de Néphrologie CHU de Bicetre, Le Kremlin Bicetre, France
This overview will cover the main development of the use of Tacrolimus in organ transplantation. It summarizes the large amount of data which have recently appeared in the literature, especially in comparison with Cyclosporine, with recent controlled conversion experience, combination therapies, withdrawal of corticosteroids, the use of Tacrolimus in monotherapy and in paediatric renal transplant patients. Finally cardiovascular risk factors are discussed in the light of the other main risk factors in this particular population of transplant patients.